Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  FibroGen Inc    FGEN

FIBROGEN INC (FGEN)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 11/17 10:00:00 pm
46.875 USD   -0.48%
11/08 FIBROGEN : reports 3Q loss
11/08 FibroGen Reports Third Quarter 2017 Financial Results
11/03 ASTELLAS PHARMA : and FibroGen Announce Positive Topline Results fro..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/13/2017 11/14/2017 11/15/2017 11/16/2017 11/17/2017 Date
46.2(c) 44.85(c) 45.05(c) 47.1(c) 46.875(c) Last
686 077 981 290 809 992 767 999 483 452 Volume
-1.96% -2.92% +0.45% +4.55% -0.48% Change
More quotes
Financials ($)
Sales 2017 133 M
EBIT 2017 -115 M
Net income 2017 -130 M
Finance 2017 648 M
Yield 2017 -
Sales 2018 253 M
EBIT 2018 -67,2 M
Net income 2018 -105 M
Finance 2018 317 B
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 24,2x
EV / Sales2018 -1 237x
Capitalization 3 863 M
More Financials
Company
FibroGen, Inc. operates as a science-based biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat unmet medical needs.It focuses on fibrosis and hypoxia-induced factor biology to generate programs targeting therapeutic areas.The... 
More about the company
Surperformance© ratings of FibroGen Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on FIBROGEN INC
11/08 FIBROGEN : reports 3Q loss
11/08 FIBROGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
11/08 FIBROGEN INC : Results of Operations and Financial Condition, Financial Statemen..
11/08 FibroGen Reports Third Quarter 2017 Financial Results
11/08 FIBROGEN INC : FibroGen, Inc. to Host Earnings Call
11/03 ASTELLAS PHARMA : and FibroGen Announce Positive Topline Results from First Japa..
11/01 FIBROGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
10/31 FIBROGEN : to Report Third Quarter Financial Results on Wednesday, November 8, 2..
10/19 FIBROGEN, INC. (NASDAQ : FGEN) Files An 8-K Financial Statements and Exhibits
10/18 FIBROGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
More news
Sector news : Biotechnology & Medical Research - NEC
11/16 Recovery rally for European stocks leaves oil sector behind
11/13 Poor earnings updates keep European shares at seven-week low
11/13DJNOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
11/03 Prosecutors search Metro offices in insider trading probe
11/01DJAs Experimental Treatments Grow, Families Face Tough Choices
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
11/09 YOUR DAILY PHARMA SCOOP : Valeant Remains Risky, Novartis's Kisqali, Tesaro Tumb..
11/08 FibroGen's (FGEN) CEO Tom Neff on Q3 2017 Results - Earnings Call Transcript
11/08 FibroGen misses by $0.13, misses on revenue
11/02 YOUR DAILY PHARMA SCOOP : Teva Q3 Results, Boost For RedHill, Clovis Reports Rub..
10/23 Disney Is A Long-Term Buy - Cramer's Lightning Round (10/20/17)
Chart FIBROGEN INC
Duration : Period :
FibroGen Inc Technical Analysis Chart | FGEN | US31572Q8087 | 4-Traders
Technical analysis trends FIBROGEN INC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 67,7 $
Spread / Average Target 44%
EPS Revisions
Managers
NameTitle
Thomas Byron Neff Chairman & Chief Executive Officer
Pat Cotroneo Chief Financial Officer & Vice President-Finance
Kin Hung Yu Chief Medical Officer
Jorma Tapio Routti Independent Director
Kalevi Kurkijärvi Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
FIBROGEN INC110.51%3 863
CELLTRION, INC.--.--%24 494
INCYTE CORPORATION4.96%22 471
IQVIA HOLDINGS INC36.54%22 070
LONZA GROUP56.09%19 543
ALNYLAM PHARMACEUTICALS, INC.236.40%12 427